MSF (MLL septin-like fusion), a fusion partner gene of MLL, in a therapy-related acute myeloid leukemia with a t(11;17)(q23;q25).

MLL (ALL1, Htrx, HRX), which is located on chromosome band 11q23, frequently is rearranged in patients with therapy-related acute myeloid leukemia who previously were treated with DNA topoisomerase II inhibitors. In this study, we have identified a fusion partner of MLL in a 10-year-old female who developed therapy-related acute myeloid leukemia 17 months after treatment for Hodgkin's disease. Leukemia cells of this patient had a t(11;17)(q23;q25), which involved MLL as demonstrated by Southern blot analysis. The partner gene was cloned from cDNA of the leukemia cells by use of a combination of adapter reverse transcriptase-PCR, rapid amplification of 5' cDNA ends, and BLAST database analysis to identify expressed sequence tags. The full-length cDNA of 2.8 kb was found to be an additional member of the septin family, therefore it was named MSF (MLL septin-like fusion). Members of the septin family conserve the GTP binding domain, localize in the cytoplasm, and interact with cytoskeletal filaments. A major 4-kb transcript of MSF was expressed ubiquitously; a 1.7-kb transcript was found in most tissues. An additional 3-kb transcript was found only in hematopoietic tissues. By amplification with MLL exon 5 forward primer and reverse primers in MSF, the appropriately sized products were obtained. MSF is highly homologous to hCDCrel-1, which is a partner gene of MLL in leukemias with a t(11;22)(q23;q11.2). Further analysis of MSF may help to delineate the function of MLL partner genes in leukemia, particularly in therapy-related leukemia.

[1]  L. Hartwell.  Genetic control of the cell division cycle in yeast. IV. Genes controlling bud emergence and cytokinesis. , 1971, Experimental cell research.

[2]  B. Haarer,et al.  Immunofluorescence localization of the Saccharomyces cerevisiae CDC12 gene product to the vicinity of the 10-nm filaments in the mother-bud neck , 1987, Molecular and cellular biology.

[3]  E. Myers,et al.  Basic local alignment search tool. , 1990, Journal of molecular biology.

[4]  A. Kerlavage,et al.  Complementary DNA sequencing: expressed sequence tags and human genome project , 1991, Science.

[5]  B. Haarer,et al.  Cellular morphogenesis in the Saccharomyces cerevisiae cell cycle: localization of the CDC3 gene product and the timing of events at the budding site , 1991, The Journal of cell biology.

[6]  P. Nowell,et al.  Cloning of ALL-1, the locus involved in leukemias with the t(4;11)(q21;q23), t(9;11)(p22;q23), and t(11;19)(q23;p13) chromosome translocations. , 1991, Cancer research.

[7]  J. Rowley,et al.  Identification of a gene, MLL, that spans the breakpoint in 11q23 translocations associated with human leukemias. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[8]  J. Pringle,et al.  Cellular morphogenesis in the Saccharomyces cerevisiae cell cycle: localization of the CDC11 gene product and the timing of events at the budding site. , 1991, Developmental genetics.

[9]  H. Alder,et al.  The t(4;11) chromosome translocation of human acute leukemias fuses the ALL-1 gene, related to Drosophila trithorax, to the AF-4 gene , 1992, Cell.

[10]  Michael L. Cleary,et al.  Involvement of a homolog of Drosophila trithorax by 11q23 chromosomal translocations in acute leukemias , 1992, Cell.

[11]  G. Evans,et al.  A trithorax–like gene is interrupted by chromosome 11q23 translocations in acute leukaemias , 1992, Nature Genetics.

[12]  P. Nowell,et al.  Cloning of the ALL-1 fusion partner, the AF-6 gene, involved in acute myeloid leukemias with the t(6;11) chromosome translocation. , 1993, Cancer research.

[13]  P. Nowell,et al.  Genes on chromosomes 4, 9, and 19 involved in 11q23 abnormalities in acute leukemia share sequence homology and/or common motifs. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[14]  J. Rowley,et al.  Rearrangement of the MLL gene in acute lymphoblastic and acute myeloid leukemias with 11q23 chromosomal translocations. , 1993, The New England journal of medicine.

[15]  J. Rowley,et al.  Rearrangements of the MLL gene in therapy-related acute myeloid leukemia in patients previously treated with agents targeting DNA- topoisomerase II , 1993 .

[16]  M. Snyder,et al.  Components required for cytokinesis are important for bud site selection in yeast , 1993, The Journal of cell biology.

[17]  M. Amylon,et al.  HRX involvement in de novo and secondary leukemias with diverse chromosome 11q23 abnormalities. , 1993, Blood.

[18]  T. P. Neufeld,et al.  The Drosophila peanut gene is required for cytokinesis and encodes a protein similar to yeast putative bud neck filament proteins , 1994, Cell.

[19]  R. Berger,et al.  A novel gene, AF-1p, fused to HRX in t(1;11)(p32;q23), is not related to AF-4, AF-9 nor ENL. , 1994, Oncogene.

[20]  J. Rowley,et al.  The balanced and the unbalanced chromosome aberrations of acute myeloid leukemia may develop in different ways and may contribute differently to malignant transformation. , 1994, Blood.

[21]  C. Croce,et al.  Leucine-zipper dimerization motif encoded by the AF17 gene fused to ALL-1 (MLL) in acute leukemia. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[22]  Y. Nakamura,et al.  Molecular cloning of a novel human cDNA homologous to CDC10 in Saccharomyces cerevisiae. , 1994, Biochemical and biophysical research communications.

[23]  J. Rowley,et al.  Cloning of ELL, a gene that fuses to MLL in a t(11;19)(q23;p13.1) in acute myeloid leukemia. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[24]  Yalin H. Wei,et al.  Cloning and characterization of the t(X;II) breakpoint from a leukemic cell line identify a new member of the forkhead gene family , 1994, Genes, chromosomes & cancer.

[25]  M. Cleary,et al.  ENL, the gene fused with HRX in t(11;19) leukemias, encodes a nuclear protein with transcriptional activation potential in lymphoid and myeloid cells. , 1994, Blood.

[26]  D. Head,et al.  Molecular analysis of 13 cases of MLL/11q23 secondary acute leukemia and identification of topoisomerase II consensus-binding sequences near the chromosomal breakpoint of a secondary leukemia with the t(4;11). , 1995, Leukemia.

[27]  W. Tse,et al.  A novel gene, AF1q, fused to MLL in t(1;11) (q21;q23), is specifically expressed in leukemic and immature hematopoietic cells. , 1995, Blood.

[28]  C. Felix,et al.  Chromosome band 11q23 translocation breakpoints are DNA topoisomerase II cleavage sites. , 1995, Cancer research.

[29]  S. Korsmeyer,et al.  Altered Hox expression and segmental identity in Mll-mutant mice , 1995, Nature.

[30]  A. Hagemeijer,et al.  The t(10;11) translocation in acute myeloid leukemia (M5) consistently fuses the leucine zipper motif of AF10 onto the HRX gene. , 1995, Blood.

[31]  Y. Ito,et al.  Subcellular localization of the alpha and beta subunits of the acute myeloid leukemia-linked transcription factor PEBP2/CBF , 1995, Molecular and cellular biology.

[32]  R. Berger,et al.  A novel class of zinc finger/leucine zipper genes identified from the molecular cloning of the t(10;11) translocation in acute leukemia. , 1995, Blood.

[33]  R. Berger,et al.  Molecular basis of IIq23 rearrangements in hematopoietic malignant proliferations , 1995, Genes, chromosomes & cancer.

[34]  Evelin Schröck,et al.  Core binding factor beta-smooth muscle myosin heavy chain chimeric protein involved in acute myeloid leukemia forms unusual nuclear rod-like structures in transformed NIH 3T3 cells. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[35]  N. Zeleznik-Le,et al.  Distribution of 11q23 breakpoints within the MLL breakpoint cluster region in de novo acute leukemia and in treatment-related acute myeloid leukemia: correlation with scaffold attachment regions and topoisomerase II consensus binding sites. , 1996, Blood.

[36]  B. Alberts,et al.  A purified Drosophila septin complex forms filaments and exhibits GTPase activity , 1996, The Journal of cell biology.

[37]  T. Rabbitts,et al.  An Mll–AF9 Fusion Gene Made by Homologous Recombination Causes Acute Leukemia in Chimeric Mice: A Method to Create Fusion Oncogenes , 1996, Cell.

[38]  M. Nakafuku,et al.  Identification of AF-6 and Canoe as Putative Targets for Ras (*) , 1996, The Journal of Biological Chemistry.

[39]  A. Bradley,et al.  Double knockout of the ALL-1 gene blocks hematopoietic differentiation in vitro. , 1996, Cancer research.

[40]  J. Karp,et al.  The secondary leukemias: challenges and research directions. , 1996, Journal of the National Cancer Institute.

[41]  C. Caldas,et al.  EEN encodes for a member of a new family of proteins containing an Src homology 3 domain and is the third gene located on chromosome 19p13 that fuses to MLL in human leukemia. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[42]  M. Cleary,et al.  Disruption of a homolog of trithorax by 11q23 translocations: leukemogenic and transcriptional implications. , 1997, Current topics in microbiology and immunology.

[43]  D. Housman,et al.  MLL is fused to CBP, a histone acetyltransferase, in therapy-related acute myeloid leukemia with a t(11;16)(q23;p13.3). , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[44]  M. Seto,et al.  Chimeric MLL products with a Ras binding cytoplasmic protein AF6 involved in t(6;11) (q27;q23) leukemia localize in the nucleus , 1997, Oncogene.

[45]  Y. Hayashi,et al.  The t(11;16)(q23;p13) translocation in myelodysplastic syndrome fuses the MLL gene to the CBP gene. , 1997, Blood.

[46]  Y. Hiraoka,et al.  Nedd5, a mammalian septin, is a novel cytoskeletal component interacting with actin-based structures. , 1997, Genes & development.

[47]  Yoshiaki Ito,et al.  The protooncogene product, PEBP2β/CBFβ, is mainly located in the cytoplasm and has an affinity with cytoskeletal structures , 1997, Oncogene.

[48]  S. Korsmeyer,et al.  Defects in yolk sac hematopoiesis in Mll-null embryos. , 1997, Blood.

[49]  R. Berger,et al.  AF6q21, a novel partner of the MLL gene in t(6;11)(q21;q23), defines a forkhead transcriptional factor subfamily. , 1997, Blood.

[50]  M. Cleary,et al.  Immortalization and leukemic transformation of a myelomonocytic precursor by retrovirally transduced HRX–ENL , 1997, The EMBO journal.

[51]  J. Ware,et al.  Alternative expression of platelet glycoprotein Ib(beta) mRNA from an adjacent 5' gene with an imperfect polyadenylation signal sequence. , 1997, The Journal of clinical investigation.

[52]  N. Speck,et al.  The Leukemic Protein Core Binding Factor β (CBFβ)–Smooth-Muscle Myosin Heavy Chain Sequesters CBFα2 into Cytoskeletal Filaments and Aggregates , 1998, Molecular and Cellular Biology.

[53]  C. Felix.  Secondary leukemias induced by topoisomerase-targeted drugs. , 1998, Biochimica et biophysica acta.

[54]  W. Honer,et al.  Localization of a novel septin protein, hCDCrel‐1, in neurons of human brain , 1998, Neuroreport.

[55]  J. Ware,et al.  Structure and expression of the human septin gene HCDCREL-1. , 1998, Gene.

[56]  E. Rappaport,et al.  t(11;22)(q23;q11.2) In acute myeloid leukemia of infant twins fuses MLL with hCDCrel, a cell division cycle gene in the genomic region of deletion in DiGeorge and velocardiofacial syndromes. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[57]  Y. Hayashi,et al.  ABI-1, a human homolog to mouse Abl-interactor 1, fuses the MLL gene in acute myeloid leukemia with t(10;11)(p11.2;q23). , 1998, Blood.